Guideline for the use of granulocyte colony stimulating ...

Multiple Myeloma (all relapsed) 30% (1), (2) All Docetaxel-based regimens (includes FEC-T) Breast (Neo-adjuvant) Breast (adjuvant) 22-36% (3), (4) ... There is some evidence that treatment soon after chemotherapy may be more beneficial than later, although, of course, G-CSF is contraindicated within 24 hours of chemotherapy, ...

  Multiple, Treatment, Myeloma, Multiple myeloma

CAPOX (XELOX) Capecitabine & Oxaliplatin

2. BCCA Protocol Summary for ADJUVANT Combination Chemotherapy for Stage III Colon Cancer Using Oxaliplatin, 5-Fluorouracil and Folinic Acid (Leucovorin). Reference: UGIAJFFOX. Mar 2006 3. Cassidy J et al (2004) XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer.

  Protocol, Cancer, Chemotherapy, Colorectal cancer, Colorectal

Northern England Clinical Networks Palliative and End of ...

• Non-drug measures- TENS, acupuncture, massage, complementary therapies, cognitive behavioural therapy • Rehabilitative support- physiotherapy, occupational therapy Adverse effects Prescribers must know the adverse effects and contraindications of all medications that they prescribe and should consult the BNF if they are unsure.

  Cognitive, Behavioural, Therapies, Cognitive behavioural

Policy for the Management of Allergic Reactions and/or ...

moderate & severe hypersensitivity reactions. To provide guidance on the treatment and management of mild, moderate & severe hypersensitivity reactions. 4. Assessment The key to successful management of anaphylaxis lies firstly in prevention and secondly in the accurate identification of the signs and symptoms of a hypersensitivity reaction.

  Cargille, Reactions, Severe, Anaphylaxis, Allergic reaction

Breast Cancer Clinical Guidelines

More than 40,000 breast cancers are diagnosed each year in the UK (1) Breast cancer causes around 13,000 deaths per annum the UK (1) One woman in 9 will develop breast cancer at some time during her lifetime. Eight of ten breast cancers occur after the menopause. Screening may reduce the chance of dying from breast cancer. It provides women

  Guidelines, Clinical, Breast, Cancer, Breast cancer clinical guidelines

FOLFOX - Oxaliplatin / Degramont

Metastatic: Tumour size and patient symptomatic response ... Dexamethasone 20 mg IV in 50 mL NS over 15 minutes (or Hydrocortisone 100mg) 30 minutes prior to Oxaliplatin ... given a copy of the DPD toxicity information leaflet from cancer research UK.

  Information, Patients, Leaflet, Information leaflet, Dexamethasone

UKALL 2011 Trial - Northern Cancer Alliance

Appendix 19 – Use Of Crisantaspase (Erwinia L-asparaginase) In Patients With Systemic Reactions To Pegaspargase (Oncaspar) ..... 189 Appendix 20 – Cytogenetic Analysis – Routine Diagnosis & Research ...

  2011, Trail, Ukall, Asparaginase, Erwinia, Ukall 2011 trial

Symptom Management Guidelines: Nausea and Vomiting

Any unnecessary medications contributing to nausea and vomiting should be discontinued (in consultation with physician and pharmacist) Select anti-nausea medication based on the cause of the nausea and vomiting, See . Appendix B Examples: High Risk Chemotherapy induced: add Aprepitant. Cannabis for refractory Opioid-induced nausea

  Induced, Chemotherapy, Nausea, Chemotherapy induced, Induced nausea

Guidelines for Prevention and Treatment of Chemotherapy ...

Chemotherapy-Induced Nausea and Vomiting in Adults . Protocol Code . SCNAUSEA : Tumour group : SUPPORTIVE CARE . Physician Contact . Dr. Wendie den Brok . ELIGIBILITY • Adults receiving chemotherapy. • Drug acquisition: Antiemetics are considered supportive treatment. These agents are not BC

  Induced, Chemotherapy, Nausea, Chemotherapy induced nausea

DRUG NAME: Palbociclib - BC Cancer

11. BC Cancer Agency. (SCNAUSEA) Guidelines for Prevention and Treatment of Chemotherapy-induced Nausea and Vomiting in Adults. Vancouver, British Columbia: BC Cancer Agency; 1 Mar 2012. 12. Pfizer Canada Inc. IBRANCE® product monograph. Kirkland, Quebec; 24 January 2020. 13. BC Cancer Breast Tumour Group.

  Induced, Chemotherapy, Nausea, Chemotherapy induced nausea

DRUG NAME: Eribulin - BC Cancer

(SCNAUSEA) Guidelines for Prevention and Treatment of Chemotherapy-induced Nausea and Vomiting in Adults. Vancouver, British Columbia: BC Cancer Agency; 1 Mar 2012. 7. BC Cancer Agency Breast Tumour Group. (UBRAVERIB) BCCA Protocol Summary for Palliative Therapy for Metastatic Breast

  Induced, Chemotherapy, Nausea, Chemotherapy induced nausea

ZOFRAN (ondansetron hydrochloride) Label

abdominal surgery or chemotherapy-induced nausea and vomiting Monitor for decreased bowel activity, particularly in patients with risk factors for gastrointestinal obstruction. (5.4) • Phenylketonuric patients should be informed that ZOFRAN ODT orally disintegrating tablets contain phenylalanine (a component of aspartame).

  Induced, Chemotherapy, Nausea, Chemotherapy induced nausea

DRUG NAME: Oxaliplatin

(grades 3-4) diarrhea, nausea and vomiting, and neurotoxicity are more common with combination ... do not appear to reduce or protect against oxaliplat in-induced neurotoxicity. 49-52. ... Chemotherapy Preparation and Stability Chart in Appendix.

  Induced, Chemotherapy, Nausea

Relaxation Techniques - National Institutes of Health

May 31, 2016 · chemotherapy-induced nausea, and . temporomandibular joint dysfunction. Psychological therapies, which may include relaxation techniques, can help manage . chronic headaches and other types of chronic pain in children and adolescents. Relaxation techniques have also been studied for other conditions,

  Technique, Induced, Relaxation, Chemotherapy, Nausea, Relaxation techniques, Chemotherapy induced nausea

HIGHLIGHTS OF PRESCRIBING INFORMATION See Full …

chemotherapy-induced nausea and vomiting is recommended. ( 2.2) •Monitor patients during the infusion and for at least 30 minutes after completion of infusion. Treatment interruption and/or dose reduction may be needed to manage adverse reactions. (2.2) •See Full Prescribing Information for preparation and administration instructions. (2.4)

  Information, Prescribing, Prescribing information, Induced, Chemotherapy, Nausea, Chemotherapy induced nausea

Dental treatment considerations in the chemotherapy patient

Hueso et al. Chemotherapy-induced acral erythema: a clinical and histopathologic study of 44 cases Actas Dermosifiliogr. 2008 Case series Boonyapakorn et al. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies. Oral Oncol. 2008 Cohort Jensen et al.

  Induced, Chemotherapy

DRUG NAME: Carboplatin - BC Cancer

Carboplatin Myelosuppression is the dose-limiting toxicity, usually manifested as thrombocytopenia and less commonly as leukopenia, neutropenia and anemia. Risk factors include prior cytotoxic therapy (especially cisplatin), poor performance status, old age, impaired renal function and concurrent myelosuppressive therapy.